SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-284125
Filing Date
2019-11-05
Accepted
2019-11-05 08:17:07
Documents
51
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d786867d10q.htm   iXBRL 10-Q 1578644
2 EX-31.1 d786867dex311.htm EX-31.1 6527
3 EX-31.2 d786867dex312.htm EX-31.2 6479
4 EX-32 d786867dex32.htm EX-32 3943
  Complete submission text file 0001193125-19-284125.txt   6277880

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA itci-20190930.xsd EX-101.SCH 32112
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20190930_cal.xml EX-101.CAL 32376
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20190930_def.xml EX-101.DEF 161719
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20190930_lab.xml EX-101.LAB 334535
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20190930_pre.xml EX-101.PRE 268253
32 EXTRACTED XBRL INSTANCE DOCUMENT d786867d10q_htm.xml XML 1313892
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 191191839
SIC: 2834 Pharmaceutical Preparations